--- title: InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution description: InsightRX earns a 96.1 KLAS score, leading in precision dosing software, helping clinicians improve patient outcomes, and expanding clinical decision support to long-term customer partnerships image: https://blog.insight-rx.com/hubfs/KLAS-emerging-company-spotlight.png --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution - Published October 7, 2025 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/KLAS-emerging-company-spotlight.png) **SAN FRANCISCO – October 7, 2025** – InsightRX, a leader in model-informed precision dosing (MIPD) software, announced today that it is the first pharmacy-focused precision dosing solution recognized in the 2025 KLAS Emerging Company Spotlight report. With an overall performance score of 96.1, placing it among the highest-rated vendors in clinical decision support, InsightRX was highlighted for its ability to improve clinician experience, support seamless EHR integration, and deliver measurable patient outcomes. ## Impact (KLAS Spotlight 2025) ### KLAS independently surveyed InsightRX customers and reported Overall performance score: **96.1** (vs. Best in KLAS average of 80.6%) Key categories: - Supports integration goals: **A+** - Product has needed functionality: **A-** - Executive involvement: **A+** - Likely to recommend: **A+** Customer loyalty: - **100%** would buy again - **100%** include InsightRX in long-term plans Outcomes delivered: - Decreased medication side effects - Higher therapeutic target attainment - Reduction in acute kidney injury - Outcomes achieved within 6 months of adoption Download the full report below ![Download the report](https://no-cache.hubspot.com/cta/default/40041574/interactive-197110812491.png) ### What Pharmacy Leaders Are Saying “The system dropped our rate of kidney injury for patients on certain antibiotics. Our estimate is that the system ultimately saves us hundreds of thousands of dollars a year.” –Manager “The integration with the EHR is InsightRx’s strength. We get real-time, immediate dosing recommendations.” –Manager ## Beyond The Spotlight: Next Generation Clinical Clinical Decision Support While the KLAS report validated InsightRX for its leadership in precision dosing and clinical decision support today, the company is already expanding its platform to reach new drug classes and therapeutic areas. A KLAS score of 96.1 is immediately relevant for hospitals managing high-risk therapies now, but the underlying platform is designed to extend far beyond current use cases. The next horizon is a future powered by InsightRX’s upcoming agentic AI system. This next generation clinical decision support tool will bring together PK/PD modeling and simulation with broader sources of clinical context, including guidelines, institutional protocols, and pharmacogenomics. By collating and reasoning across these inputs, this new platform will generate actionable insights that help optimize stewardship programs, advance antimicrobial use, and integrate genomic data into routine care. > "We are honored to be recognized by KLAS with one of the highest scores in the clinical decision support category. Their reputation is unmatched, and this validation reflects the measurable impact our platform is already having in precision dosing, > > “Our vision is to expand precision dosing to new drug classes and therapeutic areas, while building the foundation for the next generation of clinical decision support. We’re currently working to combine the proven science of PK/PD modeling with agentic AI to create smarter, more connected systems that will transform pharmacy workflows and patient care across complex therapeutic domains." - Dr. Sirj Goswami, PhD, CEO and Co-Founder of InsightRX. --- **About KLAS** [KLAS Research](https://engage.klasresearch.com/) is a leading healthcare IT research and insights firm dedicated to helping providers and payers make informed technology decisions. Through impartial, provider-driven feedback, KLAS measures vendor performance across software, services, and medical equipment to improve transparency and trust in the industry. KLAS publishes annual performance rankings and market insights that highlight innovation and measurable outcomes across healthcare technology. [KLAS](https://blog.insight-rx.com/press-releases/tag/klas) [AKI](https://blog.insight-rx.com/press-releases/tag/aki) [awards](https://blog.insight-rx.com/press-releases/tag/awards) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Press Releases Oct 4, 2023 InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023](https://blog.insight-rx.com/press-releases/insightrx-present-multiple-studies-demonstrating-advances-precision-medicine-idweek-2023) [Press Releases Dec 4, 2025 InsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing Software](https://blog.insight-rx.com/press-releases/insightrx-surpasses-1000-customer-sites) [Press Releases Dec 22, 2020 InsightRX Adds Renowned Pharmacology Experts Drs. Richard Peck And Michael Rybak To Its Scientific Advisory Board](https://blog.insight-rx.com/press-releases/renowned-pharmacology-experts-join-scientific-advisory-board) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-13T02:15:31.713Z", "datePublished" : "2025-10-07T13:10:00.000Z", "headline" : "InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution", "image" : [ "https://blog.insight-rx.com/hubfs/KLAS-emerging-company-spotlight.png" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/insightrx-klas-spotlight-report", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```